Fragile X Syndrome
Collection Requirements
Source: blood
Container: EDTA lavender
Volume:
- Preferred: 3 mL in vacutainer
- Minimum: 1 mL in vacutainer
Source: buccal/saliva
Container: OraCollect Kit
Turn Around Time
21 days
Availability
Routine
Lab Processing Instructions
Specimen: whole blood
Room temperature or refrigerate
Specimen: buccal/saliva
Room temperature
Performing Laboratory
Adele Hall
Adele Hall Lab Section
Molecular Genetics
Instrumentation/Methodology
CGG repeat sizing by PCR fragment analysis
Additional Information
Fragile X Syndrome is a trinucleotide expansion repeat disorder characterized by moderate intellectual disability and subtle dysmorphic features in affected males and variable symptoms in affected females. Affected individuals have an abnormal expansion of a CGG repeat tract in the 5’-unstranslated region of the FMR1 gene on the X chromosome (>200 CGG repeats, i.e. a full mutation). Males with CGG repeats in the premutation range (55-200) have increased risk for Fragile X Tremor/Ataxia Syndrome (FXTAS). Females with a premutation have an increased risk for Primary Ovarian Insufficiency (POI).
Reference Ranges
See interpretive report
CPT
81243